ClinicalTrials.gg
Not yet recruitingNCT07082569EYE-BREATHUpdated Jul 24, 2025

Effect of Ventilation Mode in the Pupillary Light Reflex: A Crossover Study

An interventional study of Volume Control Ventilation and Pressure Control Ventilation in Mechanical Ventilation and Critical Illness, sponsored by Evangelismos Hospital. Not yet recruiting at 1 site in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-24.

Sponsored by Evangelismos Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to explore whether different modes of mechanical ventilation affect pupillary constriction velocities in critically ill patients without brain injury. The study aims to determine whether the type of mechanical ventilation (volume control, pressure control, or pressure-regulated volume control) influences the maximum and mean constriction velocity measured by automated pupillometry. The trial also investigates whether changes in pupil dynamics reflect subtle alterations in brainstem-autonomic interaction induced by ventilation mode.

The comparison involves volume control, pressure control, and pressure-regulated volume control in a randomized crossover design to assess whether ventilation mode has a measurable effect on pupil response.

Eligible participants will be intubated ICU patients receiving assist control ventilation who are not yet ready for spontaneous breathing trials. Serial pupillometry measurements will be conducted while participants are ventilated with each mode for at least 15 minutes. Sedation and lighting conditions will remain consistent throughout the protocol. Participants with acute or chronic neurologic conditions or ventilator dyssynchrony will be excluded.

Read the detailed description

This is a prospective, randomized, crossover study designed to evaluate the effect of different modes of mechanical ventilation on pupillary constriction velocity in critically ill patients. Recent data suggest that even in the absence of direct pulmonary or neurologic injury, mechanical ventilation with positive pressure may impact brain function, possibly through vagal-brainstem-autonomic pathways. These effects may be subtle and difficult to detect with standard neurological examination but may be reflected in changes in the dynamic pupillary light reflex.

The pupillary light reflex (PLR), measured using automated infrared pupillometry, provides a quantitative, non-invasive assessment of brainstem and autonomic nervous system function. IThe investigators aim to determine whether the PLR, specifically, the mean and maximum constriction velocity, differs across three commonly used ventilation modes: Volume Control (VC), Pressure Control (PC), and Pressure-Regulated Volume Control (PRVC).

All included participants will be mechanically ventilated, sedated, and not yet candidates for spontaneous breathing trials. Exclusion criteria include any acute or chronic neurologic disorder or signs of ventilator dyssynchrony. Sedation regimens (e.g., propofol, remifentanil, dexmedetomidine) will be kept constant during the study, and ambient light will remain unchanged.

Each participant will undergo the three ventilation modes in a randomized order, with each mode applied for a minimum of 15 minutes to ensure washout before pupillometry measurements are performed. Physiological parameters such as respiratory rate, minute ventilation, FiO₂, heart rate, and mean arterial pressure will be recorded in parallel with pupil measurements. Blood gas analysis and full pupillometry data, including pupil size, constriction and dilation velocities, latency, and the Neurological Pupil Index (NPi), will also be collected.

The primary outcome is the difference in maximum pupillary constriction velocity between ventilation modes. Secondary outcomes include mean constriction velocity, NPi, and other pupillary metrics. Based on pilot data, a total of 36 participants are required to detect a significant difference in the primary outcome. Statistical analysis will include repeated measures ANOVA or the Friedman test, with post hoc Wilcoxon Signed-Rank testing as appropriate.

The findings of this study may provide support for the use of pupillometry as a tool to assess subtle CNS effects of mechanical ventilation and could support the theory of ventilation-brainstem interactions during mechanical ventilation.

02

Conditions studied

  • Mechanical Ventilation
  • Critical Illness

Browse trials for

Keywords

  • Critical illness
  • Mechanical ventilation
  • Pupillary light reflex
  • Automated pupillometry
  • Neurological Pupil Index
03

In context

Critical Illness

1,780 studies on the registry are indexed under Critical Illness; 442 are open to participants now.

This study's planned enrollment of 36 is below the median of 90 across 926 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Evangelismos Hospital is the lead sponsor of 29 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria

  • Adult patients (≥18 years old)
  • Receiving positive-pressure mechanical ventilation
  • Under light or no sedation (e.g., RASS score between -2 and 0)
  • Clinically assessed by the treating physician as not yet ready for weaning from mechanical ventilation
  • Hemodynamically stable at the time of measurement
  • Presence of an arterial catheter in place for blood gas analysis
  • Written obtained from the patient's legal representative Exclusion Criteria
  • Acute or chronic neurological disease affecting brainstem function or pupillary responses
  • Dyssynchrony with the ventilator or need for high ventilatory support adjustments
  • Facial injuries, edema, or conditions precluding accurate pupillometry
  • Use of neuromuscular blocking agents within the prior 6 hours
  • Severe metabolic or acid-base imbalances that may influence autonomic regulation
  • Concurrent participation in another interventional study that could affect neurological or autonomic outcomes
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Sequence A: VC → PC → PRVC

    Participants receive mechanical ventilation in the following sequence: Volume Control (VC), followed by Pressure Control (PC), then Pressure-Regulated Volume Control (PRVC). Pupillometry is performed after each mode following a 15-minute stabilization period.

    Other: Volume Control Ventilation · Other: Pressure Control Ventilation · Other: Pressure-Regulated Volume Control (PRVC)

  • Other
    Sequence B: VC → PRVC → PC

    Participants receive mechanical ventilation in the following sequence: Volume Control (VC), followed by Pressure-Regulated Volume Control (PRVC), then Pressure Control (PC). Pupillometry is performed after each mode following a 15-minute stabilization period.

    Other: Volume Control Ventilation · Other: Pressure Control Ventilation · Other: Pressure-Regulated Volume Control (PRVC)

  • Other
    Sequence C: PC → VC → PRVC

    Participants receive mechanical ventilation in the following sequence: Pressure Control (PC), followed by Volume Control (VC), then Pressure-Regulated Volume Control (PRVC). Pupillometry is performed after each mode following a 15-minute stabilization period.

    Other: Volume Control Ventilation · Other: Pressure Control Ventilation · Other: Pressure-Regulated Volume Control (PRVC)

  • Other
    Sequence D: PC → PRVC → VC

    Participants receive mechanical ventilation in the following sequence: Pressure Control (PC), followed by Pressure-Regulated Volume Control (PRVC), then Volume Control (VC). Pupillometry is performed after each mode following a 15-minute stabilization period.

    Other: Volume Control Ventilation · Other: Pressure Control Ventilation · Other: Pressure-Regulated Volume Control (PRVC)

  • Other
    Sequence E: PRVC → VC → PC

    Participants receive mechanical ventilation in the following sequence: Pressure-Regulated Volume Control (PRVC), followed by Volume Control (VC), then Pressure Control (PC). Pupillometry is performed after each mode following a 15-minute stabilization period.

    Other: Volume Control Ventilation · Other: Pressure Control Ventilation · Other: Pressure-Regulated Volume Control (PRVC)

  • Other
    Sequence F: PRVC → PC → VC

    Participants receive mechanical ventilation in the following sequence: Pressure-Regulated Volume Control (PRVC), followed by Pressure Control (PC), then Volume Control (VC). Pupillometry is performed after each mode following a 15-minute stabilization period.

    Other: Volume Control Ventilation · Other: Pressure Control Ventilation · Other: Pressure-Regulated Volume Control (PRVC)

Interventions

  • OtherVolume Control Ventilation

    Standard mode of mechanical ventilation delivering a preset tidal volume. Commonly used in ICU patients requiring controlled ventilation.

  • OtherPressure Control Ventilation

    Pressure-targeted ventilation mode that delivers breaths at a fixed pressure. Commonly used in critically ill patients.

  • OtherPressure-Regulated Volume Control (PRVC)

    Hybrid ventilation mode that automatically adjusts inspiratory pressure to achieve a preset tidal volume.

06

What researchers measure

Primary outcomes

  1. Maximum Pupillary Constriction Velocity

    Change in maximum pupillary constriction velocity (mm/s) in response to standardized light stimulus, as measured by the NPi-200 pupillometer, under three modes of mechanical ventilation: Volume Control (VC), Pressure Control (PC), and Pressure-Regulated Volume Control (PRVC).

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

Secondary outcomes

  1. Neurological Pupil Index (NPi)

    Change in NPi value recorded under each ventilation mode, reflecting pupillary reactivity and brainstem function.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  2. Constriction Latency

    Change in latency to onset of pupil constriction (seconds), measured using the NPi-200.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  3. Dilation Velocity

    Change in maximum dilation velocity (mm/s) following light stimulus, measured with the NPi-200.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  4. Maximum Pupil Diameter

    Change in maximum pupil diameter (mm) measured before light stimulation under each ventilation mode.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  5. Minimum Pupil Diameter

    Change in minimum pupil diameter (mm) recorded after light stimulation.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  6. Percent Constriction

    Percent change in pupil diameter from baseline in response to light stimulus.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

Other outcomes

  1. Exploratory Outcome Measure - Heart Rate Variability (HRV)

    HRV derived from ECG to explore autonomic nervous system modulation across ventilation modes (optional, if data acquisition becomes feasible).

    Time frame: Time interval between 15-30 minutes after the initiation of each ventilation mode (VC, PC, PRVC)

  2. Systolic Blood Pressure (mmHg)

    Systolic blood pressure will be recorded during each ventilation mode to assess cardiovascular stability.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  3. Diastolic Blood Pressure (mmHg)

    Diastolic blood pressure will be recorded during each ventilation mode to assess cardiovascular stability.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  4. Mean Arterial Pressure (mmHg)

    Mean arterial pressure (MAP) will be recorded to evaluate overall hemodynamic stability.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  5. Heart Rate (beats per minute)

    Heart rate will be recorded to evaluate cardiovascular stability.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  6. Arterial Partial Pressure of Oxygen, PaO₂ (mmHg)

    PaO₂ will be measured via arterial blood gas to assess oxygenation.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  7. Arterial Partial Pressure of Carbon Dioxide, PaCO₂ (mmHg)

    PaCO₂ will be measured via arterial blood gas to assess ventilation efficiency.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  8. Tidal Volume (mL)

    Tidal volume will be recorded to ensure ventilator setting consistency.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  9. Respiratory Rate (breaths per minute)

    Respiratory rate will be recorded to monitor respiratory drive and ventilation stability.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  10. Minute ventilation (L/min)

    Minute ventilation will be recorded to assess ventilatory effectiveness and ensure consistency across modes.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

  11. Ambient Illumination (lux)

    Ambient light intensity will be recorded to confirm consistent lighting conditions for pupillometry.

    Time frame: At 30 minutes after each ventilation mode initiation (VC, PC, PRVC).

07

Study locations

1 site
  • !st ICU dpt., Evangelismos Hospital
    Athens, 10676, Greece
08

References and documents

Publications

  • Sibbald B, Roberts C. Understanding controlled trials. Crossover trials. BMJ. 1998 Jun 6;316(7146):1719. doi: 10.1136/bmj.316.7146.1719. No abstract available. PubMed 9614025 ↗
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053. No abstract available. PubMed 24141714 ↗
  • Muppidi S, Adams-Huet B, Tajzoy E, Scribner M, Blazek P, Spaeth EB, Frohman E, Davis S, Vernino S. Dynamic pupillometry as an autonomic testing tool. Clin Auton Res. 2013 Dec;23(6):297-303. doi: 10.1007/s10286-013-0209-7. Epub 2013 Jul 24. PubMed 23880969 ↗
  • Bassi TG, Rohrs EC, Fernandez KC, Ornowska M, Nicholas M, Gani M, Evans D, Reynolds SC. Transvenous Diaphragm Neurostimulation Mitigates Ventilation-associated Brain Injury. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1391-1402. doi: 10.1164/rccm.202101-0076OC. PubMed 34491883 ↗
  • Cinnella G, Conti G, Lofaso F, Lorino H, Harf A, Lemaire F, Brochard L. Effects of assisted ventilation on the work of breathing: volume-controlled versus pressure-controlled ventilation. Am J Respir Crit Care Med. 1996 Mar;153(3):1025-33. doi: 10.1164/ajrccm.153.3.8630541. PubMed 8630541 ↗
  • Walter K. Mechanical Ventilation. JAMA. 2021 Oct 12;326(14):1452. doi: 10.1001/jama.2021.13084. No abstract available. PubMed 34636861 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) related to primary and secondary outcome measures will be made available to other researchers upon reasonable request, after publication of the main study results.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 6 months after publication of the primary manuscript and continuing for 3 years.

Access criteria: Access will be granted to qualified researchers for scientifically sound proposals. Requesters will need to submit a brief proposal outlining the purpose and methods of the secondary analysis.

Data sharing details ↗ · www.evaggelismos-hosp.gr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07082569
Lead sponsor
Evangelismos Hospital
Responsible party
Charikleia Vrettou (Principal Investigator, Evangelismos Hospital) — Principal investigator
First posted
Jul 24, 2025
Start date
Jul 15, 2025 (estimated)
Primary completion
Sep 15, 2025 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Jul 24, 2025

Study contacts

Charikleia S. Vrettou, MD, PhD
Contact
vrettou@hotmail.com
+302132105621 ext. 5621
Charikleia S Vrettou, MD, PhD
principal investigator · !st ICU dpt., Evangelismos General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion